These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Effect of Route of Administration and Vehicle on the Pharmacokinetics of THC and CBD in Adult, Neonate, and Breastfed Sprague-Dawley Rats. Soni I; Chinn GA; Halifax JC; Hellman J; Lynch KL; Sall JW Cannabis Cannabinoid Res; 2024 Oct; 9(5):e1443-e1451. PubMed ID: 37852006 [No Abstract] [Full Text] [Related]
9. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure. Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657 [TBL] [Abstract][Full Text] [Related]
10. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Walentiny DM; Vann RE; Wiley JL Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Moore CF; Weerts EM Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid use is enhanced by stress and changes conditioned stress responses. Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212 [TBL] [Abstract][Full Text] [Related]
14. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids. Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166 [TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of escalating cannabinoid doses in healthy cats. Kulpa JE; Paulionis LJ; Eglit GM; Vaughn DM J Feline Med Surg; 2021 Dec; 23(12):1162-1175. PubMed ID: 33769105 [TBL] [Abstract][Full Text] [Related]
16. Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101. Stollenwerk TM; Pollock S; Hillard CJ Molecules; 2021 Sep; 26(17):. PubMed ID: 34500787 [TBL] [Abstract][Full Text] [Related]
17. Effects of Tetrahydrocannabinol and Cannabidiol on Brain-Derived Neurotrophic Factor and Tropomyosin Receptor Kinase B Expression in the Adolescent Hippocampus. Winstone J; Shafique H; Clemmer ME; Mackie K; Wager-Miller J Cannabis Cannabinoid Res; 2023 Aug; 8(4):612-622. PubMed ID: 35639364 [No Abstract] [Full Text] [Related]
18. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Justinova Z; Mangieri RA; Bortolato M; Chefer SI; Mukhin AG; Clapper JR; King AR; Redhi GH; Yasar S; Piomelli D; Goldberg SR Biol Psychiatry; 2008 Dec; 64(11):930-7. PubMed ID: 18814866 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition. Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290 [TBL] [Abstract][Full Text] [Related]